In-Depth Mass Spectrometry Analysis Reveals the Plasma Proteomic and N-Glycoproteomic Impact of an Amish-Enriched Cardioprotective Variant in B4GALT1

Montasser, 2021, Genetic and functional evidence links a missense variant in B4GALT1 to lower LDL and fibrinogen, Science, 374, 1221, 10.1126/science.abe0348 Pirillo, 2021, Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis, Cardiovasc. Res., 117, 1033, 10.1093/cvr/cvaa252 Staretz-Chacham, 2020, B4GALT1-congenital disorders of glycosylation: expansion of the phenotypic and molecular spectrum and review of the literature, Clin. Genet., 97, 920, 10.1111/cge.13735 Silverman, 2016, Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis, JAMA, 316, 1289, 10.1001/jama.2016.13985 Kannel, 1987, Fibrinogen and risk of cardiovascular disease. The Framingham study, JAMA, 258, 1183, 10.1001/jama.1987.03400090067035 Roth, 2002, Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions, Chem. Rev., 102, 285, 10.1021/cr000423j Seipert, 2008, Factors that influence fragmentation behavior of N-linked glycopeptide ions, Anal. Chem., 80, 3684, 10.1021/ac800067y Mao, 2021, Systematic evaluation of fragmentation methods for unlabeled and isobaric mass tag-labeled O-glycopeptides, Anal. Chem., 93, 11167, 10.1021/acs.analchem.1c01696 Fang, 2022, Strategies for proteome-wide quantification of glycosylation macro- and micro-heterogeneity, Int. J. Mol. Sci., 23, 1609, 10.3390/ijms23031609 Blazev, 2021, Integrated glycoproteomics identifies a role of N-glycosylation and galectin-1 on myogenesis and muscle development, Mol. Cell. Proteomics, 20, 100030, 10.1074/mcp.RA120.002166 Saraswat, 2022, TMT-based multiplexed quantitation of N-glycopeptides reveals glycoproteome remodeling induced by oncogenic mutations, ACS Omega, 7, 11023, 10.1021/acsomega.1c06970 Kawahara, 2021, The complexity and dynamics of the tissue glycoproteome associated with prostate cancer progression, Mol. Cell. Proteomics, 20, 100026, 10.1074/mcp.RA120.002320 Hu, 2020, Integrated proteomic and glycoproteomic characterization of human high-grade serous ovarian carcinoma, Cell Rep., 33, 10.1016/j.celrep.2020.108276 Stadlmann, 2017, Comparative glycoproteomics of stem cells identifies new players in ricin toxicity, Nature, 549, 538, 10.1038/nature24015 Fang, 2020, A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics, Nat. Commun., 11, 5268, 10.1038/s41467-020-19052-w Hintze, 2018, Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines, J. Biol. Chem., 293, 19064, 10.1074/jbc.RA118.004516 Varki, 2008, Sialic acids in human health and disease, Trends Mol. Med., 14, 351, 10.1016/j.molmed.2008.06.002 Aoyama, 2019, Effects of terminal galactose residues in mannose alpha1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies, MAbs, 11, 826, 10.1080/19420862.2019.1608143 Shen, 2011, Terminal N-linked galactose is the primary receptor for adeno-associated virus 9, J. Biol. Chem., 286, 13532, 10.1074/jbc.M110.210922 Chen, 2020, The essential functions and detection of bisecting GlcNAc in cell biology, Front. Chem., 8, 511, 10.3389/fchem.2020.00511 Wang, 2011, Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells, Proteomics, 11, 2019, 10.1002/pmic.201000722 Nayak, 2021, System-wide quantitative N-glycoproteomic analysis from K562 cells and mouse liver tissues, J. Proteome Res., 20, 5196, 10.1021/acs.jproteome.1c00451 Halle, 1996, Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men, Arterioscler. Thromb. Vasc. Biol., 16, 144, 10.1161/01.ATV.16.1.144 Cao, 2021, Recent advances in software tools for more generic and precise intact glycopeptide analysis, Mol. Cell. Proteomics, 20, 100060, 10.1074/mcp.R120.002090 Sniderman, 2019, Apolipoprotein B particles and cardiovascular disease: a narrative review, JAMA Cardiol., 4, 1287, 10.1001/jamacardio.2019.3780 Cao, 2021, Evaluation of spin columns for human plasma depletion to facilitate MS-based proteomics analysis of plasma, J. Proteome Res., 20, 4610, 10.1021/acs.jproteome.1c00378 Geyer, 2016, Plasma proteome profiling to assess human health and disease, Cell Syst., 2, 185, 10.1016/j.cels.2016.02.015 Pernemalm, 2019, In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta, Elife, 8, 10.7554/eLife.41608 Dey, 2019, Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer's disease, Clin. Proteomics, 16, 16, 10.1186/s12014-019-9237-1 Zhu, 2020, Quantitative longitudinal inventory of the N-glycoproteome of human milk from a single donor reveals the highly variable repertoire and dynamic site-specific changes, J. Proteome Res., 19, 1941, 10.1021/acs.jproteome.9b00753 Chen, 2021, In-depth site-specific analysis of N-glycoproteome in human cerebrospinal fluid and glycosylation landscape changes in Alzheimer's disease, Mol. Cell. Proteomics, 20, 100081, 10.1016/j.mcpro.2021.100081 Shu, 2020, Large-scale identification of N-linked intact glycopeptides in human serum using HILIC enrichment and spectral library search, Mol. Cell. Proteomics, 19, 672, 10.1074/mcp.RA119.001791 Fang, 2021, Evaluation and optimization of high-field asymmetric waveform ion-mobility spectrometry for multiplexed quantitative site-specific N-glycoproteomics, Anal. Chem., 93, 8846, 10.1021/acs.analchem.1c00802